Verona Pharma plc (VRNA) Fell -10.89% or -1.68 To Price $13.75 On Friday


Verona Pharma plc (VRNA) fell -10.89% or -1.68 to $13.75. It is nearly 11161 shares traded, which is 222.42% compare to the average total volume 5018. The market cap of VRNA is $180.50 million. The year to date change is 14.15%. The 52 week price range is from $10.44 to $25.55. Price of VRNA have changed -0.13% during last week. It have changed -8.07% over last month, -24.95% over last 3 months, 36.55% over last 6 months and 27.84% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for VRNA is 16.33. It is 18.76% above current price. The 200-day Moving Averages for VRNA is 14.74. It is 7.20% above current price. The 52-week High is 25.55. It is 85.82% from the current price. The 52-week Low is 10.44. It is -24.07% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of VRNA is 0.05 on 2018-06-15. Short % to float is 0.00%. There are some statistics of VRNA. It is has market cap $180.50 million. The share outstanding is 13.13 million. The average volume is 5018. The percent of top 15 Institution holding is 44.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of VRNA is -35.85%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of VRNA is -30.22%.


Tags:

Share this post